Viewpoints: Stem Cell Agency Needs To Seize Moment And Repair Its Governance
<p>
The board overseeing California's stem cell agency will elect a new chairman this month to succeed Bob Klein, a moment that offers members an opportunity to correct the agency's dysfunctional management structure.</p>
<p>
They must also decide whether to pay Klein's successor nearly a half-million dollars.</p>
